India offering homegrown Corbevax COVID-19 vaccine to aged 12-14 years

2022-03-17 11:03:29

Asian Tech Press (Mar. 17) -- India has been administering the homegrown Corbevax COVID-19 vaccine to people aged 12-14 years since Wednesday.

Manufactured by Hyderabad-based Biological E Ltd., Corbevax is India's first indigenously developed RBD-based subunit vaccine.

In February this year, Corbevax received emergency use authorisation (EUA) from India's drug regulator for the 12-18 years age group.

Corbevax Vaccine COVID India

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Huawei's Automotive BU spin-off is in the countdown, and old employees are expected to receive extra compensation when they transfer to other companies? Insider: I haven't heard of it.
                            2024-12-27

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Henan Provincial Development and Reform Commission held a symposium on the development of new energy vehicle industry
                            2024-12-27